MYRIAD GENETICS INC — Director's Dealing 2010

Mar 5, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2010-03-03

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-03	Incentive Stock Option (right to buy)	$23.11	A	4328	Acquired	2020-03-03	Common Stock (4328)	Direct
2010-03-03	Non-Qualified Stock Option (right to buy)	$23.11	A	50672	Acquired	2020-03-03	Common Stock (50672)	Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.